Delivery Order SPE2DB20D9354-SPE2DB25FX7R7

Award Date 4/22/25
Potential Completion Date 5/13/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,543.00, is for the delivery of 4,568,166,093 units of Botox 200 unit vials. The contract has an ultimate completion date of May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $63,566.00 firm fixed-price contract is for the supply of 4,555,937,916 units of Botox 200 unit vials to support the recurring medical supply needs of military health facilities. The award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $11,075.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,564,258,790 units of Botox 100 unit vials, with an ultimate completion date of May 1, 2024. This delivery order is part of a larger $4,999,999 indefinite delivery, indefinite quantity (IDIQ) contract that DMS Pharmaceutical Group...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,251.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is to provide 4,567,552,642 units of BOTOX 100 UNIT VIALS to support the medical supply needs of military healthcare facilities. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $25,874.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 200 unit vials, with a period of performance through July 15, 2024. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 with DMS Pharmaceutical Group, which allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $46,148.00, is for the delivery of 100-unit vials of the drug Botox with a completion date of May 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, that allows...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $23,870.60, is for the delivery of 4,568,084,762 units of Botox 200 unit vials. This is a firm fixed-price delivery order contract, with a completion date of May 16, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order worth $4,625.70 with a firm fixed price and an ultimate completion date of June 2, 2025. The contract is for the delivery of 4,568,243,809 units of Botox 100 unit vials. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB25FX7R7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $22,034.40 and has an ultimate completion date of May 13, 2025.

The contract is for the delivery of 4,568,037,211 units of Botox 200 unit vials. This contract is not associated with a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide.

Generated 7/22/25, 10:11 AM